Compounded tirzepatide medical weight loss program at Pura Vida Med Spa in Fulton, MD

Fulton and Marriottsville, MD

Tirzepatide in Fulton and Marriottsville, MD

MechanismDual GIP and GLP-1 receptor agonist

AdministrationWeekly subcutaneous injection

Dose TitrationStepped over several months

Program LengthPersonalized, typically 6+ months

A Smarter Path Forward with Tirzepatide

Tirzepatide at Pura Vida Med Spa is a physician-supervised compounded weight loss program using a once-weekly dual GIP and GLP-1 receptor agonist injection - the same dual-pathway mechanism as Mounjaro and Zepbound - that activates two hunger-regulating hormones simultaneously for greater average weight reduction than single-receptor semaglutide therapies in head-to-head clinical trial data. As the most clinically powerful pharmacologic weight loss option currently available, tirzepatide is a trusted choice for patients in Fulton and Marriottsville, MD who have not achieved adequate results from semaglutide or other prior weight loss methods and are ready for the next level of metabolic support. If prior weight loss efforts have stalled and you want the most robust pharmacologic option available, tirzepatide can produce significant, lasting results without surgery, crash dieting, or downtime.

At Pura Vida Med Spa, our Fulton and Marriottsville medical team personally oversees every tirzepatide program from candidacy screening and baseline labs through stepped dose titration, side-effect management, and long-term maintenance planning. Treatments are delivered at our 8110 Maple Lawn Blvd office and our 2470 Longstone Ln. suite, where our providers customize starting dose, titration intervals, and follow-up schedule to your tolerance, comorbidities, and weight loss goals.

01 About
02 The Science
03 What We Treat
04 Benefits
05 Why Us
06 Compare

07 Treatment
08 Safety
09 Pricing
10 FAQs
11 References

How Tirzepatide Differs From Traditional GLP-1 Therapy

The dual-receptor advantage

For patients who have tried diet and exercise alone with limited results, the appetite, cravings, and metabolic resistance that come with sustained weight gain can feel impossible to overcome. Older single-pathway therapies have helped many patients, and our GLP-1 weight loss program remains an excellent option. Still, some patients want the most clinically robust pharmacologic tool available, with greater average weight reduction shown in head-to-head data.

Tirzepatide takes that next step. It activates two distinct gut hormone receptors at once, GIP and GLP-1, producing greater appetite suppression, slower gastric emptying, and improved insulin sensitivity than single-receptor therapies. In the SURMOUNT and SURPASS clinical programs, tirzepatide produced larger average weight loss than semaglutide. Under physician oversight at Pura Vida Med Spa, your dose is titrated gradually, side effects are managed, and progress is tracked with regular labs and check-ins.

What Is Tirzepatide?

Tirzepatide is a once-weekly injectable that activates two incretin receptors at once, GIP and GLP-1. The U.S. Food and Drug Administration first approved it in 2022 as Mounjaro for type 2 diabetes, then in 2023 as Zepbound for chronic weight management in adults with obesity or overweight plus a weight-related condition.

By acting on both pathways, tirzepatide slows gastric emptying, reduces appetite and cravings, and improves insulin response. In the SURMOUNT-1 trial, adults without diabetes lost roughly 15 to 20 percent of their body weight at higher doses. At Pura Vida Med Spa we prescribe a compounded formulation as part of a physician-supervised, individualized program.

Treatment Timeline:

Administration:

Once-weekly subcutaneous injection at home

First Signs:

Reduced appetite within 1 to 2 weeks

Dose Titration:

Stepped increases roughly every 4 weeks

Program Length:

Individualized, often 6 months or longer

Concerns Tirzepatide Helps With

Tirzepatide addresses targeted metabolic and weight concerns, helping reduce appetite, manage cravings, and support healthier blood sugar for meaningful, sustained weight loss

Excess Body Weight

Supports meaningful weight reduction in adults with obesity or overweight.

Stubborn Appetite

Reduces hunger signals and food noise that drive overeating.

Insulin Resistance

Improves insulin sensitivity and helps stabilize blood sugar.

Plateau After GLP-1

Offers a dual-pathway option for patients who have stalled on single-receptor therapy.

Metabolic Health

Often improves related markers like waist circumference and blood pressure.

Frequent Food Cravings

Helps quiet between-meal cravings that derail consistent progress.

Dual-Action

Activates both GIP and GLP-1 receptors

Weight Loss

A 15 to 20 percent reduction in body weight

Dosing

A weekly subcutaneous injection

Supervised

Dose change is reviewed by our medical team

Lifestyle Integration

Nutrition guidance for long-term habits

Treatment	Mechanism	Frequency	Results	Duration	Downtime	Best For
Tirzepatide	Dual GIP and GLP-1 receptor agonist	Weekly injection	Greatest average weight loss in trials	Maintained with ongoing program	None	Patients seeking robust dual-pathway therapy
GLP-1 Weight Loss	Single GLP-1 receptor agonist	Weekly injection	Significant weight loss	Maintained with ongoing program	None	Patients new to GLP-1 therapy
HCG Diet	Hormone-supported low-calorie protocol	Daily for set program length	Short-term rapid loss	Defined program window	None	Patients seeking a structured short-term reset

Who Is a Good Candidate for Tirzepatide?

Tirzepatide suits adults who meet medical criteria for weight management and want a physician-supervised program.

Ideal Candidates for Tirzepatide

Adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition
Patients who have not reached goals with lifestyle changes alone
Those who want a stronger, dual-pathway option compared to our GLP-1 weight loss program
Patients willing to follow weekly dosing, attend follow-ups, and complete required labs

Who Should Wait or Avoid Tirzepatide

Patients with a personal or family history of medullary thyroid carcinoma or MEN 2
Anyone with a history of pancreatitis or severe gastrointestinal disease
Patients who are pregnant, breastfeeding, or planning pregnancy in the near term
Those with known hypersensitivity to tirzepatide or any formulation ingredient

Talk to Us First If…

You have a history of pancreatitis, gallbladder, or thyroid (MTC/MEN2) conditions
You take other diabetes or GLP-1 medications
You have a significant gastrointestinal condition
You're pregnant, breastfeeding, or planning pregnancy soon

If any contraindication applies, our medical team will recommend safer alternatives that still support your goals.

Consultation and Labs

Our medical team reviews your history, goals, and orders baseline labs to confirm candidacy.

Starting Dose

You begin tirzepatide at the lowest dose with detailed self-injection instructions for home use.

Titration

Dose is increased in stepped intervals, typically every four weeks, based on tolerance and response.

Follow-Up

Regular check-ins track weight, side effects, vitals, and adjustments to your program.

Maintenance

Once at an effective dose, our team helps you sustain results and plan a long-term strategy.

Side Effects and Safety

Tirzepatide has a well-characterized safety profile when prescribed and monitored by qualified medical professionals.

The most common side effects are gastrointestinal and include nausea, decreased appetite, diarrhea, constipation, vomiting, fatigue, and injection site reactions. These effects are usually mild to moderate and tend to be most noticeable during dose escalation, then improve as the body adapts. Guidance from the U.S. Food and Drug Administration on GLP-1 class medications is reviewed with every patient.

Less common but important risks include pancreatitis, gallbladder disease, kidney injury related to dehydration, hypoglycemia in patients taking insulin or sulfonylureas, and serious allergic reactions. Tirzepatide carries a boxed warning for thyroid C-cell tumors based on rodent studies, so patients with a personal or family history of medullary thyroid carcinoma or MEN 2 should not use it. At Pura Vida Med Spa, every program is screened and monitored by our medical team, and any new or persistent symptoms should be reported promptly so your plan can be adjusted.

Tirzepatide Cost in Fulton, MD

Transparent, personalized pricing

Tirzepatide is priced on a monthly program basis that includes your compounded medication, supplies, and the medical oversight required to titrate safely. Because each patient progresses through doses on an individualized schedule, exact monthly pricing is confirmed during your consultation after candidacy and labs are reviewed. For many patients, tirzepatide is a meaningful investment in long-term metabolic health.

What Affects the Investment

Starting dose and titration schedule - higher doses carry a higher monthly cost
Whether baseline labs and follow-up testing are included in your plan
Program length and whether you transition to a maintenance dose
Any bundled wellness services such as IV therapy or hormone optimization

Financing Options

Pura Vida Med Spa accepts CareCredit and Cherry Financing, so you can spread the investment over the length of your program. We will walk you through any active promotions and bundled program pricing during your consultation.

To confirm your personalized tirzepatide investment, call (301) 604-8432 or book a consultation online.

Physician-Led Care

Programs designed and overseen by a board-certified physician and founder.

Personalized Titration

Doses adjusted to your tolerance, goals, and progress at each visit.

Lab and Health Monitoring

Baseline and follow-up labs keep your program safe and on track.

Two Convenient Locations

Care delivered at both our Fulton and Marriottsville, MD med spas.

Dual-Action Advantage

Tirzepatide targets both GIP and GLP-1 receptors simultaneously.

Body Composition Support

We pair Tirzepatide with Emsculpt Neo and nutritional guidance to help patients maintain muscle mass.

GLP-1 Weight Loss

Semaglutide Program with Weekly or Monthly Provider Support

Adults with BMI of 30 or higher
Adults with BMI of 27 or higher and at least one weight-related comorbidity such as hypertension, prediabetes, type 2 diabetes, or dyslipidemia
Patients committed to weekly injections and provider check-ins

HCG Diet

Structured HCG Program for Targeted Fat Loss

Adults seeking a structured, short-term, supervised weight loss framework
Patients who have stalled on conventional diet and exercise approaches
Those willing to follow a strict VLCD with weekly clinical check-ins

Hormone Replacement Therapy

Bioidentical HRT and Hormone Pellets for Women and Men

Women in perimenopause or menopause with hot flashes, night sweats, sleep changes, or vaginal dryness
Women with low libido, mood changes, or brain fog confirmed by hormone testing
Men with symptoms of low testosterone (fatigue, low libido, mood, body composition changes) plus lab confirmation

01 How is tirzepatide different from semaglutide?

Tirzepatide activates both the GIP and GLP-1 receptors, while semaglutide acts only on GLP-1. In the SURMOUNT and SURPASS trials, tirzepatide produced greater average weight loss than semaglutide at comparable timepoints.

02 How quickly will I see results with tirzepatide?

Most patients notice reduced appetite and food cravings within the first 1 to 2 weeks. Measurable weight loss typically builds over several months as the dose is titrated and lifestyle changes take hold.

03 How is tirzepatide administered?

It is a once-weekly subcutaneous injection that you self-administer at home, usually in the abdomen, thigh, or upper arm. Our medical team trains you on technique and storage during your start visit.

04 What labs are required before starting tirzepatide?

We typically order baseline labs that may include a metabolic panel, A1c, lipid panel, and other markers based on your history. Results are reviewed by our medical team before any prescription is finalized.

05 Are there side effects with tirzepatide?

The most common side effects are gastrointestinal, including nausea, mild GI changes, and fatigue, typically during dose increases. Slower titration, hydration, and meal timing strategies usually help significantly.

06 How long do I need to stay on tirzepatide?

Program length is individualized. Many patients stay on tirzepatide for 6 months or longer, and our medical team will discuss maintenance dosing or tapering strategies based on your goals and response.

Fulton8110 Maple Lawn Blvd, Suite 145
Fulton, MD, 20759(301) 604-8432

Marriottsville2470 Longstone Ln., Suite C
Marriottsville, MD, 21104(410) 816-5173

Schedule Your Tirzepatide Consultation

References

Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1, N Engl J Med 2022). PubMed (PMID: 35658024).
Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2, N Engl J Med 2021). PubMed (PMID: 34170647).
Rosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1, Lancet 2021). PubMed (PMID: 34186022).
Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2, Lancet 2023). PubMed (PMID: 37385275).
Wadden TA, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3, Nat Med 2023). PubMed (PMID: 37841220).
Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4, JAMA 2024). PubMed (PMID: 38078870).